148 related articles for article (PubMed ID: 18981086)
1. Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand.
Mossman KL; Mian MF; Lauzon NM; Gyles CL; Lichty B; Mackenzie R; Gill N; Ashkar AA
J Immunol; 2008 Nov; 181(10):6702-6. PubMed ID: 18981086
[TBL] [Abstract][Full Text] [Related]
2. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.
Ashkar AA; Mossman KL; Coombes BK; Gyles CL; Mackenzie R
PLoS Pathog; 2008 Dec; 4(12):e1000233. PubMed ID: 19057665
[TBL] [Abstract][Full Text] [Related]
3. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
Abdul-Careem MF; Firoz Mian M; Gillgrass AE; Chenoweth MJ; Barra NG; Chan T; Al-Garawi AA; Chew MV; Yue G; van Roojen N; Xing Z; Ashkar AA
Antiviral Res; 2011 Nov; 92(2):346-55. PubMed ID: 21945041
[TBL] [Abstract][Full Text] [Related]
4. FimH can directly activate human and murine natural killer cells via TLR4.
Mian MF; Lauzon NM; Andrews DW; Lichty BD; Ashkar AA
Mol Ther; 2010 Jul; 18(7):1379-88. PubMed ID: 20442710
[TBL] [Abstract][Full Text] [Related]
5. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
Habibi M; Asadi Karam MR; Bouzari S
APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627
[TBL] [Abstract][Full Text] [Related]
6. In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.
Savar NS; Jahanian-Najafabadi A; Mahdavi M; Shokrgozar MA; Jafari A; Bouzari S
J Biotechnol; 2014 Apr; 175():31-7. PubMed ID: 24530504
[TBL] [Abstract][Full Text] [Related]
7. Specific residues in the N-terminal domain of FimH stimulate type 1 fimbriae assembly in Escherichia coli following the initial binding of the adhesin to FimD usher.
Munera D; Palomino C; Fernández LA
Mol Microbiol; 2008 Aug; 69(4):911-25. PubMed ID: 18627459
[TBL] [Abstract][Full Text] [Related]
8. Allosteric coupling in the bacterial adhesive protein FimH.
Rodriguez VB; Kidd BA; Interlandi G; Tchesnokova V; Sokurenko EV; Thomas WE
J Biol Chem; 2013 Aug; 288(33):24128-39. PubMed ID: 23821547
[TBL] [Abstract][Full Text] [Related]
9.
Uchiya KI; Kamimura Y; Jusakon A; Nikai T
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30602501
[TBL] [Abstract][Full Text] [Related]
10. Integrin-like allosteric properties of the catch bond-forming FimH adhesin of Escherichia coli.
Tchesnokova V; Aprikian P; Yakovenko O; Larock C; Kidd B; Vogel V; Thomas W; Sokurenko E
J Biol Chem; 2008 Mar; 283(12):7823-33. PubMed ID: 18174167
[TBL] [Abstract][Full Text] [Related]
11. Impaired Cd14 and Cd36 expression, bacterial clearance, and Toll-like receptor 4-Myd88 signaling in caveolin-1-deleted macrophages and mice.
Tsai TH; Chen SF; Huang TY; Tzeng CF; Chiang AS; Kou YR; Lee TS; Shyue SK
Shock; 2011 Jan; 35(1):92-9. PubMed ID: 20601931
[TBL] [Abstract][Full Text] [Related]
12. Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women.
Meiland R; Geerlings SE; Langermann S; Brouwer EC; Coenjaerts FE; Hoepelman AI
J Urol; 2004 Apr; 171(4):1589-93. PubMed ID: 15017227
[TBL] [Abstract][Full Text] [Related]
13. Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic
Luna-Pineda VM; Reyes-Grajeda JP; Cruz-Córdova A; Saldaña-Ahuactzi Z; Ochoa SA; Maldonado-Bernal C; Cázares-Domínguez V; Moreno-Fierros L; Arellano-Galindo J; Hernández-Castro R; Xicohtencatl-Cortes J
Front Cell Infect Microbiol; 2016; 6():135. PubMed ID: 27843814
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: Design, synthesis and binding properties of mannoside ligands.
Sperling O; Fuchs A; Lindhorst TK
Org Biomol Chem; 2006 Nov; 4(21):3913-22. PubMed ID: 17047870
[TBL] [Abstract][Full Text] [Related]
15. Identification of FimH derivatives as adjuvant vaccinated with PAc that enhance protection against Streptcoccus mutans colonization.
Liu Z; Chen J; Li W; Bi Y; Li Y; Fan M
Mol Cell Probes; 2019 Jun; 45():19-25. PubMed ID: 30940544
[TBL] [Abstract][Full Text] [Related]
16. MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands.
Zheng H; Heiderscheidt CA; Joo M; Gao X; Knezevic N; Mehta D; Sadikot RT
Eur J Immunol; 2010 Jan; 40(1):162-71. PubMed ID: 19904768
[TBL] [Abstract][Full Text] [Related]
17.
Zhang W; Xu L; Zhang X; Xu J; Jin JO
Front Immunol; 2023; 14():1213467. PubMed ID: 37720226
[TBL] [Abstract][Full Text] [Related]
18. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
Bouckaert J; Berglund J; Schembri M; De Genst E; Cools L; Wuhrer M; Hung CS; Pinkner J; Slättegård R; Zavialov A; Choudhury D; Langermann S; Hultgren SJ; Wyns L; Klemm P; Oscarson S; Knight SD; De Greve H
Mol Microbiol; 2005 Jan; 55(2):441-55. PubMed ID: 15659162
[TBL] [Abstract][Full Text] [Related]
19. Catch-bond mechanism of the bacterial adhesin FimH.
Sauer MM; Jakob RP; Eras J; Baday S; Eriş D; Navarra G; Bernèche S; Ernst B; Maier T; Glockshuber R
Nat Commun; 2016 Mar; 7():10738. PubMed ID: 26948702
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine gate as a potential entropic lever in the receptor-binding site of the bacterial adhesin FimH.
Wellens A; Lahmann M; Touaibia M; Vaucher J; Oscarson S; Roy R; Remaut H; Bouckaert J
Biochemistry; 2012 Jun; 51(24):4790-9. PubMed ID: 22657089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
